Lumos Pharma Ownership | Who Owns Lumos Pharma?
Lumos Pharma Ownership Summary
Lumos Pharma is owned by 25.08% institutional investors, 32.69% insiders, and 42.23% retail investors. Wells fargo & company/mn is the largest institutional shareholder, holding 5.12% of LUMO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.17% of its assets in Lumos Pharma shares.
LUMO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lumos Pharma | 25.08% | 32.69% | 42.23% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Wells fargo & company/mn | 414.98K | 5.12% | $962.75K |
| Goldman sachs group | 406.61K | 5.02% | $943.34K |
| Vanguard group | 244.08K | 3.01% | $566.27K |
| Renaissance | 215.81K | 2.66% | $500.69K |
| Jefferies financial group | 120.65K | 1.49% | $279.91K |
| Lion point capital, lp | 90.79K | 1.12% | $210.64K |
| Greenwich wealth management | 76.34K | 0.94% | $177.00K |
| Geode capital management | 50.73K | 0.63% | $117.71K |
| Blackrock | 41.10K | 0.51% | $95.36K |
| Millennium management | 37.02K | 0.46% | $85.88K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lion point capital, lp | 90.79K | 0.38% | $210.64K |
| Wealth advisors of iowa | 11.70K | 0.02% | $27.14K |
| Greenwich wealth management | 76.34K | 0.01% | $177.00K |
| Paladin advisory group | 4.39K | 0.01% | $9.93K |
| Key financial | 10.93K | 0.01% | $25.35K |
| Jefferies financial group | 120.65K | 0.00% | $279.91K |
| Bridgeway capital management | 27.64K | 0.00% | $64.13K |
| Renaissance | 215.81K | 0.00% | $500.69K |
| Private advisor group | 30.01K | 0.00% | $69.63K |
| West financial advisors | 784.00 | 0.00% | $1.82K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Private advisor group | 30.01K | 0.00% | 14.00K |
| Citadel advisors | 18.75K | - | 5.46K |
| Envestnet asset management | 19.48K | - | 3.36K |
| Geode capital management | 50.73K | - | 3.13K |
| Tower research capital llc (trc) | 3.58K | 0.00% | 891.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Acuitas investments | - | - | -141.44K |
| Blackstone | - | - | -78.62K |
| Two sigma advisers, lp | - | - | -31.90K |
| Marquette asset management | - | - | -25.76K |
| Two sigma investments, lp | 18.95K | 0.00% | -19.87K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Live oak investment partners | 11.00 | - | 11.00 | $26.00 |
| Jones financial companies lllp | 4.00 | - | 4.00 | $9.00 |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -3.00 |
| Global retirement partners | -11.00 |
| International assets investment management | -38.00 |
| Group one trading | -150.00 |
| Redwood wealth management group | -500.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 28 | -20.00% | 2,088,151 | 0.49% | 25 | 3.81% | 5 | -61.54% | 10 | 42.86% |
| Jun 30, 2024 | 35 | - | 2,077,959 | -4.52% | 25 | 3.55% | 13 | 30.00% | 7 | - |
| Mar 31, 2024 | 35 | -5.41% | 2,176,429 | -8.07% | 26 | 3.05% | 10 | -9.09% | 7 | 40.00% |
| Dec 31, 2023 | 37 | 12.12% | 2,367,466 | -3.00% | 29 | 3.32% | 11 | 37.50% | 5 | -54.55% |
| Sep 30, 2023 | 33 | -2.94% | 2,440,661 | 1.96% | 29 | 3.54% | 8 | -11.11% | 11 | 83.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 187.32K | 2.17% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 50.83K | 0.59% | - |
| Fidelity Extended Market Index | 30.66K | 0.35% | 2.58K |
| Bridgeway Ultra-Small Company Market | 18.74K | 0.22% | -8.00K |
| Fidelity Nasdaq Composite Index | 10.04K | 0.12% | - |
| Fidelity Series Total Market Index | 7.10K | 0.08% | 1.73K |
| DFA US Targeted Value I | 6.64K | 0.08% | - |
| Vanguard Instl Ttl Stck Mkt Idx Tr | 5.93K | 0.07% | - |
| BlackRock Extended Equity Market K | 5.58K | 0.07% | -2.00 |
| Vanguard Instl Ttl Stk Mkt Idx InstlPls | 5.93K | 0.07% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 02, 2023 | McKew John C. | Chief Scientific Officer | Sell | $10.92K |
| Apr 04, 2023 | McKew John C. | Chief Scientific Officer | Sell | $7.24K |
| Feb 02, 2023 | McKew John C. | Chief Scientific Officer | Sell | $1.55K |
| Nov 16, 2022 | McCracken Joseph S | - | Buy | $20.12K |
| Sep 23, 2022 | Hawkins Richard J | Chief Executive Officer | Buy | $1.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | - |
| 2024 Q1 | - | - |
| 2023 Q3 | - | 1 |
| 2023 Q2 | - | 1 |
| 2023 Q1 | - | 1 |
LUMO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools